Our findings reveal a novel feedback loop regulation between NOTCH1 and USP11, underline the role of active deubiquitination in cancer, and provide a rationale for therapeutic targeting of USP11 in acute lymphoblastic leukemia. The gene discussed is NOTCH1; the disease is cancer.